MedPath
Found 70 clinical trials|View Analysis
Sort by:

Oral Nicotine Pouches Versus Nicotine Replacement Therapy to Reduce Cigarette Use for Smokers in Rural Appalachia

Not Applicable
Not yet recruiting
Conditions
Cigarette Smoking-Related Carcinoma
Interventions
Procedure: Carbon Monoxide Measurement
Other: Internet-Based Intervention
Drug: Nicotine Oral Pouch
Drug: Nicotine Lozenge
Other: Survey Administration
Drug: Nicotine Patch
First Posted Date
2025-01-08
Last Posted Date
2025-01-08
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
1000
Registration Number
NCT06763536
Locations
🇺🇸

Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Pharmacokinetics and Comparative Bioavailability of Nicotine From Two Variants of NP2, NP2-4mg and NP2-6mg, Compared to Nicotine Lozenge 4mg (Loz-4mg) and Nicotine Gum 4mg (Gum-4mg)

Not Applicable
Completed
Conditions
Tobacco Use
Interventions
Other: NP2-4mg
Other: NP2-6 mg
Other: Loz-4mg
Other: Gum-4mg
First Posted Date
2023-12-14
Last Posted Date
2024-08-13
Lead Sponsor
Philip Morris Products S.A.
Target Recruit Count
56
Registration Number
NCT06171490
Locations
🇨🇦

Pharma Medica Research Inc., Toronto, Ontario, Canada

🇨🇦

Syneos Health Clinique Inc., Québec, Canada

Feasibility of Delivering VergeRx at FQHCs

Not Applicable
Recruiting
Conditions
Tobacco Use Cessation
Interventions
Behavioral: QuitAid
Behavioral: SmokefreeTXT
Drug: Nicotine Replacement Therapy Patch
Drug: Nicotine lozenge
First Posted Date
2023-12-08
Last Posted Date
2024-12-13
Lead Sponsor
University of Virginia
Target Recruit Count
100
Registration Number
NCT06161675
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

CAN-DOSE Study: Cessation With Augmented Nicotine for Dual Use Of Smoking and E-cigarettes

Phase 2
Completed
Conditions
Smoking Cessation
Electronic Cigarette Use
Cigarette Smoking
Interventions
Drug: Augmented Nicotine patch and lozenge dose
Drug: Regular Nicotine patch and lozenge dose
First Posted Date
2023-10-17
Last Posted Date
2024-11-11
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
45
Registration Number
NCT06087328
Locations
🇺🇸

Medical University of South Carolina - Charleston, Charleston, South Carolina, United States

Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in Appalachia

Not Applicable
Recruiting
Conditions
Smoking Cessation
Smoking, Cigarette
Smoking Reduction
Smoking
Smoking, Tobacco
Quitting Smoking
Interventions
Drug: 4 weeks of Nicotine lozenge
Drug: 8 weeks of Nicotine Replacement Therapy Patch
Behavioral: QuitAid
Behavioral: Smokefree TXT
Drug: 4 weeks of Nicotine Replacement Therapy Patch
Drug: 8 Weeks Nicotine Lozenge
Behavioral: Tobacco Quitline
First Posted Date
2022-12-21
Last Posted Date
2024-08-27
Lead Sponsor
University of Virginia
Target Recruit Count
768
Registration Number
NCT05660525
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS)

Not Applicable
Recruiting
Conditions
Smoking Cessation
Cervical Cancer
High Grade Cervical Dysplasia
Interventions
Behavioral: Smoking Cessation treatment delivered by Tobacco Free Florida Quitline
Drug: Nicotine Lozenge
Drug: Nicotine patch
Behavioral: Motivation and Problem Solving (MAPS) intervention
First Posted Date
2022-12-09
Last Posted Date
2024-12-09
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
360
Registration Number
NCT05645146
Locations
🇺🇸

Moffitt Cancer Center, Tampa, Florida, United States

Free Samples for Health

Phase 2
Conditions
Cigarette Smoking
Interventions
First Posted Date
2022-11-25
Last Posted Date
2024-05-30
Lead Sponsor
Hennepin Healthcare Research Institute
Target Recruit Count
1200
Registration Number
NCT05627596
Locations
🇺🇸

Hennepin Healthcare Research Institute, Minneapolis, Minnesota, United States

Quit or Switch: E-cigarette Study

Not Applicable
Completed
Conditions
Tobacco Use
Interventions
Behavioral: e-cigarette
Other: Nicotine patch, Nicotine lozenge
First Posted Date
2022-09-01
Last Posted Date
2024-04-26
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
30
Registration Number
NCT05525078
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Integrating Tobacco Use Cessation Into HIV Care and Treatment in Kisumu County, Kenya

Phase 4
Recruiting
Conditions
Tobacco Use
Tobacco Use Cessation
Interventions
Behavioral: Tobacco Use Cessation Counselling Sessions
Drug: Bupropion
Drug: Nicotine patch
Drug: Nicotine lozenge
First Posted Date
2022-04-28
Last Posted Date
2024-07-12
Lead Sponsor
University of California, San Francisco
Target Recruit Count
580
Registration Number
NCT05351606
Locations
🇰🇪

Kenya Medical Research Institute (KEMRI), Kisumu, Kenya

Easy Access to Smoking Cessation for People Receiving Opioid Agonist Therapy Who Are Smoking Tobacco

Not Applicable
Active, not recruiting
Conditions
Smoking Cessation
Substance-Related Disorders
Interventions
Drug: Nicotine patch
Drug: Nicotine gum
Drug: Nicotine lozenge
Behavioral: Smoking cessation counselling
Other: Screening for use of tobacco products
Other: Screening for interest in smoking cessation
First Posted Date
2022-03-22
Last Posted Date
2024-06-28
Lead Sponsor
Haukeland University Hospital
Target Recruit Count
266
Registration Number
NCT05290025
Locations
🇳🇴

LAR Helse Stavanger HF, Stavanger, Norway

🇳🇴

Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway

© Copyright 2025. All Rights Reserved by MedPath